USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medtronic Minimed, Inc.

USPTO PatentsView assignee record - 769 granted patents across 82 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

769
Total patents granted
82
CPC technology areas
17.9
Avg claims per patent
+22%
5-year filing velocity

The verdict

Medtronic holds 769 US patents across 82 technology areas, rank #585 of 50,000 tracked assignees.

#585
of 50,000 US assignees by volume
Top 1%
by Innovation Score (67.5/100)
17.9
avg claims per patent
+22%
filing velocity, last 5 yrs

Portfolio overview

Medtronic Minimed, Inc. has been granted 769 US utility patents between 2015 and 2025, placing Medtronic Minimed, Inc. at rank #585 across all assignees tracked by PlainPatent. This portfolio spans 82 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Medtronic Minimed, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Medtronic sits between Novozymes A/s (770 patents, rank #581) and Hanon Systems (758 patents, rank #589) - the closest US assignees by grant volume. The composite Innovation Score of 67.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 423 grants, compared with 346 in the 2015–2019 window, a +22% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medtronic Minimed, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 82 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Minimed, Inc. against peers pursuing similar technology classes.

Who files at Medtronic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medtronic holds 769 patents at rank #585, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medtronic

By rank, the assignees closest to #585 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Medtronic's primary technology class.

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

406080100 20152016201720182019202020212022202320242025 61
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medtronic Minimed, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 58 7.5%
2016 71 9.2%
2017 72 9.4%
2018 67 8.7%
2019 78 10.1%
2020 65 8.5%
2021 47 6.1%
2022 65 8.5%
2023 88 11.4%
2024 97 12.6%
2025 61 7.9%

Which technologies does Medtronic Minimed, Inc. patent most?

Top 15 of 82 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#585

Across all tracked assignees

Innovation Score

67.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medtronic Minimed, Inc. hold?
Medtronic Minimed, Inc. holds 769 US granted patents filed between 2015 and 2025, spanning 82 technology areas.
What is Medtronic Minimed, Inc.'s Innovation Score?
Medtronic Minimed, Inc. has an Innovation Score of 67.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medtronic Minimed, Inc. focus on?
Medtronic Minimed, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 577 patents. The company has filed patents in 82 CPC subclasses total.
Is Medtronic Minimed, Inc.'s patent filing rate increasing or decreasing?
Medtronic Minimed, Inc.'s recent filing velocity is +22% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Medtronic Minimed, Inc.'s patents?
Medtronic Minimed, Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medtronic Minimed, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medtronic's 769 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Medtronic ranks #585 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.